
The insights provide no actionable buy or sell signals for CMCSA, AMGN, META, TMUS, or BA: lobbying activity is context for monitoring policy exposure, not evidence of investment impact. Track relevant regulatory developments and lobbying disclosures, but wait for company-specific financial or valuation evidence before making a trade.